These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29349485)

  • 1. Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.
    DiMarco A; Christakis I; Constantinides V; Regan L; Palazzo FF
    World J Surg; 2018 Mar; 42(3):639-645. PubMed ID: 29349485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and primary hyperparathyroidism (PHPT).
    Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective study on incidence of primary hyperparathyroidism in patients with goiter].
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Pol Merkur Lekarski; 2006 Nov; 21(125):469-73. PubMed ID: 17345842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
    Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
    Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study.
    Massironi S; Cavalcoli F; Rossi RE; Conte D; Spampatti MP; Ciafardini C; Verga U; Beck-Peccoz P; Peracchi M
    Eur J Endocrinol; 2013 May; 168(5):755-61. PubMed ID: 23447517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
    Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
    J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
    Lim V; Clarke BL
    J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperparathyroidism.
    Silva BC; Cusano NE; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack].
    Velayoudom-Cephise FL; Foucan L; Soudan B; Cardot-Bauters C; Vantyghem MC; D'herbomez M; Tison-Muchery F; Wemeau JL
    Presse Med; 2011 Feb; 40(2):e120-7. PubMed ID: 21036004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
    Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
    Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
    Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
    J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
    Shah VN; Shah CS; Bhadada SK; Rao DS
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
    Tucci JR
    Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on the presentation of primary hyperparathyroidism.
    Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.